Although cardiovascular disease remains the leading proximate cause of death in the United States, it is now estimated that obesity may be equivalent to smoking as the leading cause of preventable death in America. In light of these statistics, this reference presents our current understanding of t
Cardiovascular Plaque Rupture (Fundamental and Clinical Cardiology, 45)
β Scribed by David Brown
- Year
- 2002
- Tongue
- English
- Leaves
- 544
- Edition
- 1
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Synopsis
Illustrating the development and determinants of possible plaque rupture, Cardiovascular Plaque Rupture provides an in-depth review of the pathology, etiology, cellular and molecular biology, diagnosis, and treatment of plaque in the cardiovascular system-exploring the roles of physical stress, inflammation, and infectious agents on the growth of cardiovascular disease. Characterize and identify vulnerable plaque using novel imaging modalities and modifications of existing invasive and noninvasive technologies! Containing recent data on preventive gene therapy and antibiotic stabilization of plaque, >Cardiovascular Plaque Rupture considers Β·serine proteinase and metalloproteinase inhibitors in the prevention of plaque rupture Β·lipid lowering to stabilize plaque Β·clinical trial designs to demonstrate therapeutic prevention of plaque rupture Β·and more! Discussing current methods of plaque assessment, including intravascular ultrasound and elastography, in vivo spectroscopic analysis, optical coherence tomography, thermography, and magnetic resonance imaging, Cardiovascular Plaque Rupture is an indispensable guide for cardiologists, vascular and cardiac surgeons, radiologists, vascular biologists, endocrinologists, and fellows, residents, and medical school students in these disciplines.
π SIMILAR VOLUMES
These multidisciplinary presentations provide information essential to devising effective drug protocols in cardiovascular drug development, facilitating the approval process. Guides researchers and developers through the government drug approval process, facilitating development, minimizing costs,
Cardiovascular disease, including heart disease, peripheral arterial disease, and stroke, is the leading cause of illness and death in the United States. Filling a gap in the literature, this reference contains expert contributions on the care and management of patients at high-risk for cardiovascul
Cardiovascular disease, including heart disease, peripheral arterial disease, and stroke, is the leading cause of illness and death in the United States. Filling a gap in the literature, this reference contains expert contributions on the care and management of patients at high-risk for cardiovascul
Individuals 65 years of age or older currently account for over eighty percent of all cardiovascular disease-related deaths. With advances and breakthroughs in modern medicine that are allowing people to live longer, the number of older adults in this country will continue to grow exponentially over
Presents up-to-date knowledge concerning the pathophysiology of cardiovascular disorders and therapeutic advances for treating elderly cardiac patients. This second edition contains new chapters and updated information on the efficiency and adverse reactions of commonly used and newly developed card